semaglutide drink GLP-1 reduces heavy drinking days in treatment seeking people with alcohol use disorder and obesity, finds small trial Many patients taking GLP-1 medications

Batch-specific values such as purity percentage, assay amount, residual solvents, water content, heavy metals, microbial limits, oxidation state, or pass/fail results should only be stated when supported by a current lot-specific certificate of analysis

Women with autoimmune conditions affecting the stomach (such as pernicious anaemia or atrophic gastritis), inflammatory bowel disease , or those taking long-term metformin (MHRA advises monitoring B12 levels in at-risk patients) or proton pump inhibitors also have increased risk

New Beauty and The New York Times recently posted articles on skin care after weight loss from GLP-1 agonists

These coordinated effects collectively promote hepatic metabolic homeostasis restoration